Toshiro Matsui Selected Research

Toshiro Matsui Research Topics

Disease

7	Inflammation (Inflammations) 10/2019 - 01/2011
6	Colitis 01/2021 - 11/2012
5	Atherosclerosis 11/2021 - 02/2010
4	Body Weight (Weight, Body) 04/2023 - 02/2010
4	Neoplasms (Cancer) 01/2020 - 06/2010
4	Hypertension (High Blood Pressure) 12/2017 - 10/2002
3	Cognitive Dysfunction 03/2024 - 08/2018
3	Glucose Intolerance 10/2019 - 08/2015
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 02/2017
2	Breast Neoplasms (Breast Cancer) 01/2020 - 10/2018
2	Prediabetic State (Prediabetes) 09/2017 - 08/2015
2	Weight Loss (Weight Reduction) 02/2015 - 11/2012
1	Atherosclerotic Plaque (Atheroma) 11/2021
1	Atrophy 09/2021
1	Muscular Atrophy (Muscle Atrophy) 09/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2019
1	Type 2 Diabetes Mellitus (MODY) 10/2019
1	Hypercholesterolemia 12/2017
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 02/2017
1	Insulin Resistance 11/2016
1	Edema (Dropsy) 11/2014
1	Bacterial Infections (Bacterial Infection) 01/2012
1	Fatty Liver 01/2010

Drug/Important Bio-Agent (IBA)

7	Peptides (Polypeptides)IBA 09/2021 - 11/2006
4	Dextrans (Dextran)FDA Link 02/2017 - 02/2015
4	sodium sulfate (sodium bisulfate)FDA LinkGeneric 02/2017 - 02/2015
4	tryptophyl-histidineIBA 07/2015 - 02/2010
3	DipeptidesIBA 03/2024 - 02/2010
3	Pyruvaldehyde (Methylglyoxal)IBA 10/2019 - 08/2015
3	Blood Glucose (Blood Sugar)IBA 09/2017 - 08/2015
3	CytokinesIBA 07/2015 - 11/2012
2	AcidsIBA 01/2020 - 01/2010
2	Advanced Glycation End ProductsIBA 10/2019 - 09/2017
2	Proteins (Proteins, Gene)FDA Link 10/2019 - 06/2018
2	imidazoloneIBA 09/2017 - 08/2015
2	Glucose (Dextrose)FDA LinkGeneric 11/2016 - 08/2015
2	Antihypertensive Agents (Antihypertensives)IBA 11/2006 - 10/2002
1	Adiponectin ReceptorsIBA 03/2024
1	tyrosyl-proline (Tyr-Pro)IBA 03/2024
1	Hempa (Hexamethylphosphoramide)IBA 04/2023
1	1-penicillamyl-Leu(2)- oxytocinIBA 11/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2021
1	LipidsIBA 11/2021
1	Ligases (Synthetase)IBA 09/2021
1	UbiquitinIBA 09/2021
1	PolyvinylsIBA 01/2021
1	Phenobarbital (Luminal)FDA Link 01/2021
1	Therapeutic UsesIBA 01/2021
1	Butyrates (Butyrate)IBA 01/2021
1	Cholecalciferol (Vitamin D3)FDA Link 01/2021
1	Culture MediaIBA 01/2020
1	Amyloid beta-PeptidesIBA 01/2020
1	nonanalIBA 01/2020
1	AldehydesIBA 01/2020
1	decanaldehyde (decanal)IBA 01/2020
1	cetyl alcohol FDA LinkGeneric 01/2020
1	heptanalIBA 01/2020
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2020
1	caprylic aldehydeIBA 01/2020
1	argpyrimidineIBA 10/2019
1	GlyceraldehydeIBA 10/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2019
1	PolyphenolsIBA 10/2018
1	Estrogens (Estrogen)FDA Link 10/2018
1	Untranslated RNA (Noncoding RNA)IBA 10/2018
1	Estrogen ReceptorsIBA 10/2018
1	glyceollinIBA 10/2018
1	Soybean Proteins (Soy Protein)IBA 08/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 08/2018
1	DNA (Deoxyribonucleic Acid)IBA 06/2018
1	RNA (Ribonucleic Acid)IBA 06/2018
1	N(6)-carboxymethyllysine (carboxymethyllysine)IBA 09/2017
1	isomaltodextrinIBA 02/2017
1	Polysaccharides (Glycans)IBA 02/2017
1	Adenine FDA LinkGeneric 06/2016
1	NucleotidesIBA 03/2016
1	Blood Proteins (Serum Proteins)IBA 08/2015
1	Drinking WaterIBA 02/2015
1	ConalbuminIBA 02/2015
1	CarrageenanIBA 11/2014
1	Interleukin-17 (Interleukin 17)IBA 11/2012
1	VPY tripeptideIBA 11/2012
1	Interleukin-6 (Interleukin 6)IBA 11/2012
1	ZincIBA 01/2012
1	ThermolysinIBA 01/2012
1	Virulence Factors (Pathogenicity Factors)IBA 01/2012
1	Metalloproteases (Metalloproteinases)IBA 01/2012
1	chungkookjangIBA 01/2011
1	Silk FDA Link 06/2010
1	Fibroins (Fibroin)IBA 06/2010
1	Apolipoproteins E (ApoE)IBA 02/2010
1	PhytochemicalsIBA 02/2010
1	TeaIBA 01/2010
1	Lipase (Acid Lipase)FDA Link 01/2010
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2006
1	Conjugated Linoleic AcidsIBA 06/2003

Therapy/Procedure

6	Oral Administration 01/2021 - 05/2010
2	Therapeutics 10/2018 - 11/2012
1	Denervation 09/2021